InsidersTradesSigma
Track the 百普赛斯 share price and the full directors' dealings record of the company, a listed issuer based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 百普赛斯 has recorded 4 reports. Market capitalisation: €8.7bn. The latest transaction was disclosed on 4 December 2025 (Sale). Among the most active insiders: 苗景赟. The full history is openly available.
4
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€239,306
4 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 12,501 of 29,064 companies
55.6
score / 100
Value33
Quality78
FCF yld1.7%
Earn yld1.9%
EV/EBITDA36.7x
ROE6.4%
Gross mgn91%
Net mgn20%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 4 December 2025
关于 百普赛斯
百普赛斯是一家在医疗保健和制药领域运营的公司，在 XSHE 市场上市。它专注于药品的开发和商业化。